A novel approach to sustained pseudoephedrine release: Differentially coated mini-tablets in HPMC capsules

International Journal of Pharmaceutics

Volumn 359, Issue 1-2, 2008, Pages 46-52

  Ishida, Makoto ^a   Abe, Kenichi ^a   Hashizume, Minoru ^a   Kawamura, Masao ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Ethylcellulose; Hydroxypropyl methylcellulose; Immediate release; Mini tablets; Pseudoephedrine hydrochloride; Sustained release

Indexed keywords

DISINTEGRATING AGENT; ETHYL CELLULOSE; EXCIPIENT; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; PSEUDOEPHEDRINE; WATER;

ARTICLE; DRUG CAPSULE; DRUG COATING; ENCAPSULATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET; THICKNESS; TIME;

CAPSULES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; METHYLCELLULOSE; NASAL DECONGESTANTS; PSEUDOEPHEDRINE; SOLUBILITY; TABLETS; TIME FACTORS;

EID: 44749083182     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.03.034     Document Type: Article

References (25)

1. Bechgaard H., and Nielsen G.H. Controlled-release multiple-units and single-unit doses. A literature review. Drug Dev. Ind. Pharm. 4 (1978) 53-67
2. Caravati E.M. Reconsidering the safety of over-the-counter decongestants. Ann. Emerg. Med. 45 (2005) 217-218
3. Chiwele I., Jones B.E., and Podczeck F. The shell dissolution of various empty hard capsules. Chem. Pharm. Bull. 48 (2000) 951-956
4. Colombo P., Conte U., Caramella C., Gazzaniga A., and La Manna A. Compressed polymeric mini-matrices for drug release control. J. Control. Release 1 (1985) 283-289
5. Cox P.J., Khan K.A., Munday D.L., and Sujja-areevath J. Development and evaluation of a multiple unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics. Int. J. Pharm. 193 (1999) 73-84
6. De Brabander C., Vervaet C., Fiermans L., and Remon J.P. Matrix mini-tablets based on starch/microcrystalline wax mixtures. Int. J. Pharm. 199 (2000) 195-203
7. Eccles R., Jawad M.S., Jawad S.S., Angello J.T., and Druce H.M. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am. J. Rhinol. 19 (2005) 25-31
8. Follonier N., and Doelker E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S.T.P. Pharma. Sci. 2 (1992) 141-158
9. Ito Y., Kusawake T., Ishida M., Tawa R., Shibata N., and Takada K. Oral solid gentamicin preparation using emulsifier and adsorbent. J. Control. Release 105 (2005) 23-31
10. Jawad S.S., and Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 36 (1998) 73-76
11. Kanfer I., Dowse R., and Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 13 (1993) 116S-128S
12. Kawashima Y., Takeuchi H., Hino T., Niwa T., Lin T.L., Sekigawa F., and Kawahara K. Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation. J. Pharm. Sci. 10 (1993) 351-355
13. Kranz H., Le Brun V., and Wagner T. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug. Int. J. Pharm. 299 (2005) 84-91
14. Lopes C.M., Sousa Lobo J.M., Costa P., and Pinto J.F. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release. Drug Dev. Ind. Pharm. 32 (2006) 95-106
15. Makhija S.N., and Vavia P.R. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. J. Control. Release 89 (2003) 5-18
16. Mukesh C.G., and Manhapra S.G. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend. J. Control. Release 79 (2002) 157-164
17. Nagai T., Sekigawa F., and Hoshi N. Applications of HPMC and HPMCAS aqueous film coating of pharmaceutical dosage forms. In: McGinity J.M. (Ed). Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms (1989), Marcel Dekker, New York 81-152
18. Nakagami H., and Nada M. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets. Drug. Des. Deliv. 7 (1991) 321-332
19. Østberg T., Lund E.M., and Graffner C. Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics in different media. Int. J. Pharm. 112 (1994) 241-248
20. Prasad Y.V.R., Eaimtrakarn S., Ishida M., Kusawake Y., Tawa R., Yoshikawa Y., Shibata N., and Takada K. Evaluation of oral formulations of gentamicin containing Labrasol in beagle dogs. Int. J. Pharm. 268 (2003) 13-21
21. Sakellariou P., and Rowe R.C. The morphology of blends of ethylcellulose with hydroxypropyl methylcellulose as used in film coating. Int. J. Pharm. 125 (1995) 289-296
22. Sujja-areevath J., Munday D.L., Cox P.J., and Khan K.A. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur. J. Pharm. Sci. 6 (1998) 207-217
23. Tan Y.T.F., Heng P.W.S., and Wan L.S.C. Mixed polymer coating for modified release from coated spheroids. Pharm. Dev. Technol. 4 (1999) 561-570
24. Tanaka N., Imai K., Okimoto K., Ueda S., Tokunaga Y., Ohike A., Ibuki R., Higaki K., and Kimura T. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J. Control. Release 108 (2005) 386-395
25. Waterman K.C., and Fergione M.B. Press-coating of immediate release powders onto coated controlled release tablets with adhesives. J. Control. Release 89 (2003) 387-395